Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Rangering i aksjer #14767
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Aksjekurs
$16.85
Sist synkronisert: 2023-07-07
Markedsverdi
$393.50M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CH
Handel VectivBio Holding AG (VECT)

Kategori

Historikk for aksjesplitt for VectivBio Holding AG (VECT)
Aksjen VectivBio Holding AG (symbol: VECT) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 01, 2026.
Én VECT-aksje kjøpt før Sep 01, 2026 tilsvarer i dag 0 VECT-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH